News

The Teal Wand is an at-home vaginal self-collection device intended to test for 14 types of high-risk HPV that have the highest risk for causing cervical cancer.
New epinephrine nasal spray dosage approved for pediatrics; FDA agree to review semaglutide for weight management; wearable defibrillator cleared to prevent sudden cardiac arrest; a low dose ...
Icotrokinra led to high rates of skin clearance in patients with scalp and genital psoriasis, according to results from the ICONIC-TOTAL study.
Increased risk for attacks seen in women younger than 35 years, those with eosinophilia, those with lower corticosteroid use.
In a recent study, protective association lasted for up to eight years, with greatest reduction seen at two to three years postvaccination.
HealthDay News — North Dakota is the latest state to find itself dealing with a measles outbreak, becoming the 11th state in the nation to face the challenge, the Associated Press is reporting.
The prescription device is a wearable belt that includes a motor designed to transmit low amplitude, high frequency vibration to the spine and hips.
Nirsevimab associated with lower odds of RSV-related hospitalization, ICU admission, lower respiratory tract infection incidence.
Terminations resulted in $1.81 billion in terminated grant funding; 30% had not been expended at time of termination.
The Food and Drug Administration (FDA) has granted accelerated approval to Avmapki ™ (avutometinib) plus Fakzynja ™ (defactinib) for the treatment of adult patients with KRAS -mutated recurrent ...
Reproxalap is a first-in-class small-molecule modulator of reactive aldehyde species, which are generally elevated in ocular and systemic inflammatory disease.